Novo Nordisk (NVO)
(Delayed Data from NYSE)
$126.85 USD
+1.06 (0.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $126.90 +0.05 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 21% (198 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.54 | 2.10 | 9.99 |
Current Quarter Estimate | 0.77 | 37.64 | 60.00 |
Year Ago Quarter Estimate | 0.64 | 11.39 | 52.54 |
Next Quarter Estimate | 0.82 | 34.85 | 61.00 |
Next Year Estimate | 4.09 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 22.96 | 3.90 | 17.08 |
Next Year | 23.19 | 16.10 | 8.00 |
Last 5 Years | 17.00 | 3.00 | 8.10 |
Next 5 Years | 18.00 | 11.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 46.50 | 15.53 |
Price/Book (MRQ) | 36.48 | 5.30 |
Price/Cash Flow (MRFY) | 41.78 | 10.16 |
Dividend Yield | 1.05% | 2.85% |
Net Profit Margin (TTM) | 36.03% | 45.26% |
Return on Equity (TTM) | 90.36% | 36.43% |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.